SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 06/26/2019
Entire Document
 

 

In re: Pernix Sleep, Inc. et al. Case No. 19-10323 (CSS)
Debtors Reporting Period: April 1, 2019 -April 30, 2019

 

MOR - 1b
Schedule of Debtor Bank Account Balances (1)
For the Period: April 1, 2019 -April 30, 2019
(Unaudited)

 

$ USD '000s
Debtor
Bank Last Four Digits
Account No.
Account Description Beginning
Balance
4/1/2019
Ending
Balance
4/30/2019
Pernix Therapeutics LLC Wells Fargo 2816 Pernix zero-balance lockbox $-  $- 
Cypress Pharmaceuticals, Inc. Wells Fargo 5673 Cypress zero-balance lockbox  -   - 
Pernix Therapeutics LLC Wells Fargo 2824 Pernix Operating  8,314,020   - 
Cypress Pharmaceuticals, Inc. Wells Fargo 2865 Cypress Operating  4,754,921   - 
Pernix Therapeutics Holdings, Inc. Wells Fargo 3388 Pernix Holdings  5,138   3,600,000 
Pernix Ireland Pain Designated Activity Company Allied Irish Bank 3508 PIPDAC Operating  16,101   475 
Pernix Ireland Limited Allied Irish Bank 8061 PIL Operating (EUR)(2)  55,108   346 
Pernix Ireland Pain Designated Activity Company Allied Irish Bank 3187 PIPDAC Operating (EUR)(2)  3,069   346 
Pernix Therapeutics LLC Wells Fargo 2840 Pernix Payroll  -   5,871,619 
Pernix Therapeutics LLC Wells Fargo 2832 Pernix FSA  -   - 
Macoven Pharmaceuticals LLC Wells Fargo 5186 Utility adequate assurance deposit  6,751   2,696,999 
Pernix Therapeutics LLC Wells Fargo 0526 Nalpropion receipts escrow account  2,772,023   810,227 
Total Bank Account Balances       $15,927,130  $12,980,013 

 

Notes:

(1) The Consolidated Schedule of Cash Receipts and Disbursements (MOR-1) and Schedule of Disbursements by Debtor Entity (MOR-1a) represent book balances while MOR-1b represents bank balances. The balances differ primarily due to the bank’s delayed recording of intrabank activity between the general checking and sweep accounts. 

(2) The EUR accounts are presented in USD and translated at the daily FX rate based upon the statement date.

 

8